The emerging therapy of this peptide represents a significant development in the care of type 2 diabetes. Distinct from existing therapies, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide156729.jiliblog.com/98417352/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment